CR9679A - Nuevos compuestos 1,1-piridinilamino-ciclopropanaminas polisustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen - Google Patents

Nuevos compuestos 1,1-piridinilamino-ciclopropanaminas polisustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen

Info

Publication number
CR9679A
CR9679A CR9679A CR9679A CR9679A CR 9679 A CR9679 A CR 9679A CR 9679 A CR9679 A CR 9679A CR 9679 A CR9679 A CR 9679A CR 9679 A CR9679 A CR 9679A
Authority
CR
Costa Rica
Prior art keywords
pyridinylamine
cyclopropanamine
composites
new
pharmaceutical compositions
Prior art date
Application number
CR9679A
Other languages
English (en)
Inventor
Solo Goldstein
Claude Guillonneau
Yves Charton
Brian Lockhart
Pierre Lestage
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of CR9679A publication Critical patent/CR9679A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compuestos de formula (I) en la que: n representa un numero entero comprendido entre 1 y 6 inclusive, R1 y R2 representan un atomo de hidrogeno, un grupo alquilo (C1-C6) o arilalquilo (C1-C6), R3 y R4 representan un atomo de hidrogeno, un grupo alquilo (C1-C6), R5 y R6 representan un atomo de hidrogeno, un grupo alquilo (C1-C6), halogeno, hidroxi, alcoxi (C1-C6), ciano, nitro, acilo (C2-C6), alcoxicarbonilo (C1-C6), trihalogenoalquilo (C1-C6), trihalogenoalcoxi (C1-C6) o amino sustituidos opcionalmente, R7 representa un atomo de hidrogeno, un grupo alquilo (C1-C6) o arilalquilo.
CR9679A 2005-07-28 2008-01-22 Nuevos compuestos 1,1-piridinilamino-ciclopropanaminas polisustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen CR9679A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508032A FR2889188B1 (fr) 2005-07-28 2005-07-28 Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
CR9679A true CR9679A (es) 2008-02-20

Family

ID=36169157

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9679A CR9679A (es) 2005-07-28 2008-01-22 Nuevos compuestos 1,1-piridinilamino-ciclopropanaminas polisustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen

Country Status (31)

Country Link
US (2) US7388022B2 (es)
EP (1) EP1757586B1 (es)
JP (1) JP2007031439A (es)
KR (1) KR100824831B1 (es)
CN (1) CN100448848C (es)
AR (1) AR055589A1 (es)
AT (1) ATE416166T1 (es)
AU (1) AU2006203237A1 (es)
BR (1) BRPI0603027A (es)
CA (1) CA2552831A1 (es)
CR (1) CR9679A (es)
DE (1) DE602006003956D1 (es)
DK (1) DK1757586T3 (es)
EA (1) EA011124B1 (es)
EC (1) ECSP088127A (es)
ES (1) ES2318700T3 (es)
FR (1) FR2889188B1 (es)
GE (1) GEP20084506B (es)
GT (1) GT200800005A (es)
HR (1) HRP20090090T3 (es)
MA (1) MA28425B1 (es)
MX (1) MXPA06008541A (es)
NO (1) NO20063462L (es)
NZ (1) NZ548746A (es)
PL (1) PL1757586T3 (es)
PT (1) PT1757586E (es)
SG (1) SG129412A1 (es)
SI (1) SI1757586T1 (es)
TN (1) TNSN08023A1 (es)
WO (1) WO2007012761A1 (es)
ZA (1) ZA200606276B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2896800B1 (fr) * 2006-01-30 2008-04-11 Servier Lab Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US10288289B2 (en) * 2014-12-12 2019-05-14 United Technologies Corporation Gas turbine engine diffuser-combustor assembly inner casing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2095350C1 (ru) * 1993-10-13 1997-11-10 Центр по химии лекарственных средств (ЦХЛС-ВНИХФИ) 3-(n,n-диметилкарбамоилокси)-2-этил-6-метилпиридина сукцинат, обладающий антигипоксической активностью
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
EE04588B1 (et) * 1997-10-27 2006-02-15 Neurosearch A/S Heteroarüüldiasatsükloalkaanid kui atsetüülkoliini nikotiinretseptorite kolinergilised ligandid, nende kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
EP1185514A1 (en) * 1999-06-07 2002-03-13 Targacept, Inc. Pharmaceutical compositions and methods for use
JP2001261652A (ja) * 2000-03-21 2001-09-26 Suntory Ltd 二置換イミノヘテロサイクリック化合物
US6448276B1 (en) * 2000-05-17 2002-09-10 Inspire Pharmaceuticals, Inc. Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists
FR2810664B1 (fr) * 2000-06-27 2004-12-24 Adir Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
EP1757586A1 (fr) 2007-02-28
ATE416166T1 (de) 2008-12-15
DK1757586T3 (da) 2009-03-09
US20080146621A1 (en) 2008-06-19
MXPA06008541A (es) 2007-01-29
ZA200606276B (en) 2007-12-27
EP1757586B1 (fr) 2008-12-03
TNSN08023A1 (en) 2009-07-14
NZ548746A (en) 2007-06-29
NO20063462L (no) 2007-01-29
AU2006203237A1 (en) 2007-02-15
KR100824831B1 (ko) 2008-04-23
SI1757586T1 (sl) 2009-04-30
US20070027192A1 (en) 2007-02-01
WO2007012761A1 (fr) 2007-02-01
ES2318700T3 (es) 2009-05-01
GEP20084506B (en) 2008-10-10
FR2889188A1 (fr) 2007-02-02
FR2889188B1 (fr) 2007-09-07
HK1098146A1 (zh) 2007-07-13
CA2552831A1 (fr) 2007-01-28
BRPI0603027A (pt) 2007-03-13
GT200800005A (es) 2008-09-24
DE602006003956D1 (en) 2009-01-15
PT1757586E (pt) 2009-02-17
HRP20090090T3 (en) 2009-03-31
JP2007031439A (ja) 2007-02-08
KR20070015012A (ko) 2007-02-01
SG129412A1 (en) 2007-02-26
US7388022B2 (en) 2008-06-17
MA28425B1 (fr) 2007-02-01
PL1757586T3 (pl) 2009-04-30
CN1903844A (zh) 2007-01-31
EA200601247A1 (ru) 2007-04-27
AR055589A1 (es) 2007-08-29
ECSP088127A (es) 2008-02-20
WO2007012761A8 (fr) 2007-12-21
CN100448848C (zh) 2009-01-07
EA011124B1 (ru) 2008-12-30

Similar Documents

Publication Publication Date Title
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
GT200500119A (es) Derivados de tetraazabenzo [e] azuleno y sus analogos
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
UY28572A1 (es) Compuestos novedosos
CR8402A (es) Indazol-o-glucosidos sustitutos
ATE437205T1 (de) Styrylsulfidfarbstoffe
NO20090175L (no) Stabile laquinimod sammensetninger
UY28342A1 (es) Nuevos compuestos
CR9081A (es) Inhibidores de la interaccion entre mdm2 y p53
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
AR069531A1 (es) Derivados de indolinona y procedimiento para su fabricacion
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
UY29360A1 (es) Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones.
CY1108797T1 (el) Α-κρυσταλλικη μορφη του ρανελικου στροντιου, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις που την περιεχουν
BR0305767A (pt) Métodos e composições para a preparação de derivados de ácido 4-substituìdo 3-hidroxibutìrico
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
UY31712A1 (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
UY28694A1 (es) Nuevos compuestos
PA8768301A1 (es) Nuevos derivados tricíclicos, su procedimiento de preparación y las composiciones farmacéuticas que lo contienen
UY29234A1 (es) Derivados de adamantano, composiciones farmacéuticas que los contienen, procedimientos de preparación de ambos y aplicaciones.
NO20054787L (no) Indenderivater som farmasotiske midler
PA8589801A1 (es) Aminoalcoxiindoles
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)